WallStSmart
CVKD

Cadrenal Therapeutics, Inc. Common Stock

NASDAQ: CVKD · HEALTHCARE · BIOTECHNOLOGY

$6.67
+19.32% today

Updated 2026-04-30

Market cap
$13.79M
P/E ratio
P/S ratio
EPS (TTM)
$-6.64
Dividend yield
52W range
$4 – $17
Volume
0.1M

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-19.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+32.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+15.3%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-1.41$4.25$4.90+15.3%
2025-12-31$-1.41-16.5%$6.62$7.33+10.7%
2025-11-06$-1.31+5.8%$12.75$12.15-4.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-1.41
2025-12-31$-1.21$-1.41-16.5%
2025-09-30$-1.39$-1.31+5.8%
2025-06-30$-1.26$-1.87-48.4%
2025-03-31$-2.15$-2.09+2.8%
2024-12-31$-0.15$-2.55-1600.0%$2134.00-22.9%
2024-09-30$-0.12$-2.18-1716.7%
2024-06-30$-0.12$-2.25-1775.0%
2024-03-31$-0.07$-0.10-42.9%
2023-12-31$-0.08$-0.05+37.5%$2768.00
2023-09-30$-0.08

Frequently asked questions

Has Cadrenal Therapeutics, Inc. Common Stock beaten earnings estimates?
Cadrenal Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -19.7% over the last 3 quarters.
How does CVKD stock react to earnings?
CVKD stock has moved an average of +7.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.